Copyright
©The Author(s) 2020.
World J Clin Oncol. Sep 24, 2020; 11(9): 732-746
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.732
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.732
Figure 2 Diacerein treatment attenuates the expression of pro-inflammatory cytokines.
A: Quantitative reverse transcription polymerase chain reaction analysis of interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α genes in peritumoral colonic tissue of Swiss mice treated with vehicle or diacerein50 (n = 17–18 mice/group); B: Quantification of serum IL-1β, IL-6 and TNF-α (n = 6–10 mice/group); C: Analysis of pro-inflammatory protein expression (p-IKK, p-JNK) by immunoblot in the peritumoral colonic tissue (Supplementary Figure 1). Data are presented as mean ± standard error. aP < 0.05.
- Citation: Paulino DSM, Mendes MCS, Camargo JA, Brambilla SR, Wood Dos Santos T, Ribeiro ML, Carvalheira JBC. Diacerein treatment prevents colitis-associated cancer in mice. World J Clin Oncol 2020; 11(9): 732-746
- URL: https://www.wjgnet.com/2218-4333/full/v11/i9/732.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i9.732